CD44 and cancer: Combined with the existing reports [24] and GBP1-regulated AS events, we finally obtained a regulatory pathway, that is, GBP1 and HNRNPK binding, through the A3SS alternative splicing form, regulate the expression of CD44 protein, and finally play a cancer-promoting role in cervical cancer.